- Investing Ideas
- /
- Global Potential Buyback Winners
Global Potential Buyback Winners
UPDATED May 20, 2024
Most likely to generate positive returns on buybacks.
633 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BFH | US$41.43 | -0.2% | 35.9% | US$2.1b | US$41.36 | PE4.9x | E-0.6% | 2.0% | Diversified Financials | ||
SAH | US$57.55 | -1.1% | 40.8% | US$2.0b | US$58.00 | PE11.3x | E14.7% | 2.1% | Retail | ||
VET | CA$16.76 | 3.6% | 2.9% | CA$2.7b | CA$20.95 | PS1.5x | E48.5% | 2.9% | Energy | ||
NVA | CA$12.94 | 1.3% | 11.4% | CA$2.7b | CA$16.12 | PE8.3x | E24.4% | n/a | Energy | ||
HR.UN | CA$9.54 | 3.9% | -7.3% | CA$2.7b | CA$11.13 | PB0.5x | E86.4% | 7.3% | Real Estate | ||
CWB | CA$27.28 | -0.5% | 9.3% | CA$2.6b | CA$33.90 | PB0.7x | E11.2% | 5.0% | Banks | ||
FTAL | ₪430.70 | -4.6% | 26.7% | ₪7.1b | n/a | PE183.2x | n/a | n/a | Consumer Services | ||
SINCH | kr24.16 | 10.9% | 0.4% | kr20.4b | kr42.38 | PE657.6x | E55.5% | n/a | Software | ||
EXPI | US$12.43 | -1.1% | -18.4% | US$1.9b | US$11.58 | PB8.7x | E171.2% | 1.6% | Real Estate Management and Development | ||
HLMN | US$9.69 | 1.9% | 18.9% | US$1.9b | US$12.00 | PS1.3x | E43.3% | n/a | Capital Goods | ||
STGW | US$7.03 | 0.7% | 12.8% | US$1.9b | US$8.21 | PB2.4x | E70.7% | n/a | Media | ||
DUE | €24.34 | -2.6% | -14.7% | €1.7b | €29.73 | PE15.4x | E22.7% | 2.9% | Capital Goods | ||
NVAX | US$14.79 | 12.8% | 96.2% | US$1.8b | US$19.75 | PS2.1x | E71.5% | n/a | Pharmaceuticals & Biotech | ||
POM | €11.59 | -0.9% | -26.7% | €1.7b | €14.05 | PE10.2x | E18.1% | 3.4% | Automobiles | ||
WGO | US$61.45 | -5.0% | 8.8% | US$1.8b | US$76.44 | PE15.5x | E25.1% | 2.0% | Automobiles | ||
PTGX | US$31.26 | 6.6% | 22.1% | US$1.8b | US$43.50 | PE11.3x | E0.8% | n/a | Pharmaceuticals & Biotech | ||
NEU | AU$20.73 | 2.6% | 44.3% | AU$2.7b | AU$26.13 | PE16.9x | E0.8% | n/a | Pharmaceuticals & Biotech | ||
TWEKA | €41.24 | 4.6% | -12.1% | €1.6b | €53.34 | PE9.9x | E6.2% | 4.1% | Capital Goods | ||
UPBD | US$32.09 | -3.2% | 2.1% | US$1.8b | US$41.83 | PB3x | E34.6% | 4.6% | Retail | ||
HEES | US$48.57 | -1.4% | 26.8% | US$1.8b | US$66.40 | PE10.3x | E5.6% | 2.3% | Capital Goods | ||
VCYT | US$22.30 | -0.9% | -15.2% | US$1.7b | US$29.83 | PS4.5x | E123.7% | n/a | Pharmaceuticals & Biotech | ||
CWH | US$20.52 | -7.2% | -21.2% | US$1.7b | US$28.27 | PE166.1x | E111.7% | 2.4% | Retail | ||
PXT | CA$23.22 | -3.6% | -17.2% | CA$2.4b | CA$30.40 | PE4.2x | S0.5% | 6.4% | Energy | ||
XRX | US$13.93 | 2.1% | -5.0% | US$1.7b | US$15.00 | PB0.7x | E30.0% | 7.2% | Tech |